Private equity holds 33,575 unsold portfolio companies as exit valuations stall

Private equity firms now hold 33,575 portfolio companies they cannot exit at prices limited partners will accept, according to a New York Times investigation published Monday. The figure represents a 47% increase from 22,800 companies held in inventory at the start of 2023, even as July global PE and venture capital deal value reached $43.31 billion—up for the second consecutive month.

The contradiction is structural. Firms continue deploying capital into new acquisitions—KKR closed a $5.7 billion take-private of medical equipment maker Integer Holdings last week—while legacy funds languish with aging positions acquired between 2018 and 2021. Brookfield Asset Management and Warburg Pincus led July's deal surge, but neither firm has materially accelerated exits from funds raised before the rate cycle turned. The inventory buildup spans all fund vintages: 62% of companies held beyond their original exit windows sit in funds closed between 2017 and 2020, according to Preqin data through Q2 2026.

The accumulation creates cascading pressure across the capital stack. Limited partners—family offices, endowments, sovereign wealth vehicles—face $487 billion in unfunded commitments to new vintage years while waiting on distributions from funds now in years eight through twelve. Denominator effects force allocators into uncomfortable choices: default on capital calls and lose access to oversubscribed GPs, or sell secondary stakes at discounts widening to 18-22% of NAV for mid-market funds. The secondary market absorbed $134 billion in transaction volume through July, but bid-ask spreads remain 9-14 percentage points wider than historical norms. Sellers take the loss; buyers inherit positions with compressed return profiles.

The mismatch between entry activity and exit capacity exposes the fee arbitrage at private equity's core. Management fees accrue on invested capital regardless of realization timelines, creating institutional incentive to deploy into frothy markets while avoiding markdown pain. Firms raised $728 billion in new commitments during 2025, but distributed only $312 billion to LPs—the widest gap since 2008. This is not a liquidity crisis in the traditional sense. It is a valuation standoff. GPs will not crystallize losses that trigger clawback provisions or damage track records needed for next fundraises. LPs cannot force sales without jeopardizing relationships that govern access to top-quartile managers. The result: portfolios age in place.

Allocators should monitor three indicators through Q4 2026. First, continuation fund activity—GPs moving stale assets into new vehicles, resetting fee clocks without returning capital. These transactions accounted for $67 billion in volume through July, up 34% year-over-year, and represent the cleanest way to defer valuation recognition. Second, the spread between EBITDA multiples paid for new platform acquisitions versus exit multiples achieved in the same sector—currently 2.3 turns wide in software, 1.8 turns in healthcare services. Third, the percentage of funds extending beyond their contractual term by twelve months or more, now 41% of funds raised before 2019. Extensions signal limited partners already voted to wait rather than force fire sales.

The inventory pile does not unwind through optimism. It unwinds through operating performance that justifies entry prices, or through time that makes current valuations acceptable relative to newer alternatives. Firms adding to the pile today are betting the denominator problem solves itself before the next downturn. The 33,575 companies waiting for exits suggest otherwise.